ITMCTR2100005224尚未招募1 期
Clinical Observation on Treating Moderate and Severe Ulcerative Colitis with Bupiwei Xieyinhuo Shengyang supplemented decoction
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational study
入排标准
- 年龄范围
- 18 至 65（—）
- 性别
- All
入选标准
- •(1) 18 years of age to 65 years of age, regardless of gender;
- •(2) In line with the modern medical diagnosis of ulcerative colitis, patients with moderate to severe active ulcerative colitis. The modified Mayo score is 6-12 points.
- •(3) Chronic recurrence type or persistent type, with a medical history of more than 6 months.
- •(4) Those who voluntarily participate in this clinical trial, have informed consent and signed an informed consent form.
排除标准
- •(1) Pregnant or lactating women, patients with recent birth plans;
- •(2) Confirmed or suspected bacterial dysentery, amoebic dysentery, intestinal schistosomiasis, intestinal tuberculosis, fungal colitis, antibiotic-related colitis, eosinophilic colitis, Behcet's disease, Crohn Diseases, ischemic enteritis, radiation enteritis, indeterminate colitis, colonic diverticulitis, colorectal cancer;
- •(3) The subject has diseases such as the heart, lung, liver, kidney, cardiovascular, endocrine system, immune system, hematopoietic system, and nervous system, and the researcher believes that it will interfere with the research results or endanger the safety of the subject;
- •(4) Gastrointestinal diseases and surgery that affect drug absorption, and colon surgery is expected to be performed within 12 weeks after enrollment;
- •(5) Those who suspect or do have a history of alcohol or drug abuse;
- •(6) Participated in other drug clinical trials within the past one month;
- •(7) Those who are in critical condition and are difficult to make an accurate assessment of the effectiveness and safety of the drug;
- •(8) ALT, AST=1.5 times the upper limit of normal, Scr>1.5 times the upper limit of normal;
- •(9) Complications, such as intestinal obstruction, intestinal perforation, toxic colon dilation, and lower gastrointestinal bleeding;
- •(10) Those who have contraindications to colonoscopy;
- •(11) According to the researcher's judgment, those who are likely to be lost to follow-up or other reasons that are not suitable for selection.
研究者
相似试验
招募中
Unknown
Clinical observation on the treatment of moderate female stress urinary incontinence with optimized formula of Qishi granules based on the theory of spleen kidney correlatioFemale stress urinary incontinenceITMCTR2024000008Xiyuan Hospital, China Academy of Chinese Medical Sciences
进行中（未招募）
3 期
Evaluation of a standard treatment regimen of anti-tuberculosis drugs for patients with MDR-TBCTRI/2017/09/009693The international Union Against Tuberculosis and lung diseases
招募中
不适用
Evaluation of treatment regimes in patients with cystic fibrosis and pulmonary excerbations (PEx)E84.0Cystic fibrosis with pulmonary manifestationsDRKS00012924Klinik für Pädiatrie m. S. Pneumologie und ImmunologieCampus Rudolf Virchow Klinikum100
尚未招募
3 期
A comparative clinical study on the management of urticaria by the oral use of adraka khanda with or without nimbadi lepaCTRI/2024/08/072289Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital
招募中
不适用
Investigation of clinical course and treatment of acute exacerbation of interstitial lung disease - A Prospective Observational StudyJPRN-UMIN000043154Hamamatsu University School of Medicine400